Results 141 to 150 of about 55,959 (291)

A Case of Drug‐Induced Pancreatitis

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Drug‐induced pancreatitis (DIP) is a rare but important cause of acute abdominal pain, and ciprofloxacin‐associated cases are exceptionally uncommon. We report a 35‐year‐old woman with no significant medical history who developed severe epigastric pain radiating to the back, accompanied by nausea and vomiting, 3 days after initiating self ...
Muskan Shrestha   +5 more
wiley   +1 more source

QT PRODACT: Sensitivity and Specificity of the Canine Telemetry Assay for Detecting Drug-Induced QT Interval Prolongation

open access: bronze, 2005
Hiroyasu Miyazaki   +7 more
openalex   +2 more sources

Large Language Models for Clinical Trial Protocol Assessments

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 393-402, February 2026.
The purpose was to evaluate the utility of large language models (LLMs) for reviewing the statistical analysis plan (SAP) and pharmacokinetics–pharmacodynamics (PK–PD) components of clinical trial protocols. Clinical trial protocols and SAPs were obtained from clinicaltrials.gov for a testbed of 15 small‐molecule drugs, biologics, and global antibiotic
Euibeom Shin   +2 more
wiley   +1 more source

Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia. [PDF]

open access: yesInt J Vasc Med, 2022
Gaviria-Mendoza A   +4 more
europepmc   +1 more source

Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 503-513, February 2026.
Potential adverse drug events can be signaled in Clinical Decision Support Systems (CDSSs). This study validated a Swedish CDSS (Janusmed Risk Profile) by investigating associations between calculated risk classifications of drugs with QT‐prolonging potential and registered related clinical outcomes.
Ola Nordqvist   +6 more
wiley   +1 more source

QT INTERVAL PROLONGATION IS A NOVEL PREDICTOR OF 1-YEAR MORTALITY IN PATIENTS WITH COVID-19 INFECTION [PDF]

open access: yesJ Am Coll Cardiol, 2022
Banai A   +10 more
europepmc   +2 more sources

Salbutamol-Induced QT Interval Prolongation in a Two-Year-Old Patient. [PDF]

open access: yesCureus, 2022
Elgassim M   +7 more
europepmc   +1 more source

QT Interval Prolongation Predicts Cardiovascular Mortality in an Apparently Healthy Population

open access: yesCirculation, 1991
E. Schouten   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy